A Open-label Study of Ultra-High Dose Dexamethasone for Relapsed Multiple Myeloma
NCT02402725
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
poor accrual
Conditions
Multiple Myeloma
Interventions
DRUG:
Dexamethasone
Sponsor
Boston Medical Center